Drugs / AV650
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00456560 | Apr → May 2007 | — | Avigen | Completed | No outcome recorded |
| Phase 1 | NCT00364039 | Aug 2006 → ? | — | Avigen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AV650 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00364039 ↗ |
| Route | Oral | “Single Oral Dose of AV650 (300 mg)” NCT00456560 ↗ |